mesoestetic Pharma Group
Yara Mariaud has a diverse work experience, starting as a Flight Attendant at Aeroméxico from 1992 to 2000. Yara then worked as an Account Executive at Mar Borque y Asociados, a Public Relations and Communications agency, from 2001 to 2002. Yara then moved on to Pierre Fabre Ibérica, a pharmaceutical laboratory, where they worked as a Marketing Assistant from 2004 to 2011. During their time at Pierre Fabre Ibérica, they focused on organizing scientific events in the field of oncology and hematology. Lastly, Yara Mariaud joined mesoestetic Pharma Group in 2011 as the Head of Events and Congresses. In this role, they were responsible for coordinating the company's presence in major aesthetic and dermatological medical congresses and fairs worldwide, as well as organizing national and international professional and corporate events.
Yara Mariaud's education history begins with their earning a degree in "Licenciatura en Relaciones Públicas" from Universidad del Valle de México between 1996 and 2000. Yara then pursued a Master's degree in Organizational Communication Management from Universitat de Girona - Escuela Superior de Marketing y Administración (ESMA) from 2000 to 2001. In 2008 and 2009, Yara completed a Product Manager Postgraduate Program at EADA Escuela de Alta Dirección y Administración. Most recently, in 2021, they attended [IM] Digital Business School to study Organization of Digital Events.
This person is not in any teams
mesoestetic Pharma Group
mesoestetic Pharma Group is a pharmaceutical laboratory internationally recognized as one of the leaders in the field of dermatology and aesthetic medicine offering innovative and efficient solutions for skin treatment and care. The company manufactures cosmeceutical, nutraceuticals, class III intradermal administration medical devices with CE conformity marking, topical drugs as well as energy based medical aesthetic devices. This full range of integral aesthetic solutions is characterized by a high degree of innovation and significant scientific contribution. Since its inception in 1984, the firm has been committed to meeting strict pharmaceutical standards and complying with the most stringent European regulations. The company facilities are authorized by the Spanish Agency for Medicines and Medical Devices (AEMYPS) and include three pharmaceutical manufacturing lines (cosmeceuticals and nutraceuticals / intradermal administration medical devices / injectable and topical drugs), as well as a Biotechnology Unit and a Monitoring and Follow-Up Unit. These units enable the company to cover the entire production cycle and carry out in vitro and in vivo studies to ensure the safety and efficacy of its products.